Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Feb 15, 2024 | Option Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Feb 20, 2024, 04:03 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Feb 15, 2024 | Sale | $37.75 | 2,915 | 110,041 | 1,764 | Feb 20, 2024, 04:03 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Dec 28, 2021 | Buy | $12.96 | 3,433 | 44,476 | 3,433 | Feb 13, 2024, 04:00 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Jan 16, 2024 | Option Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Jan 18, 2024, 04:10 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Jan 16, 2024 | Sale | $37.97 | 2,915 | 110,683 | 1,764 | Jan 18, 2024, 04:10 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Dec 15, 2023 | Option Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Dec 19, 2023, 04:00 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Dec 15, 2023 | Sale | $36.12 | 2,915 | 105,290 | 1,764 | Dec 19, 2023, 04:00 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Nov 15, 2023 | Option Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Nov 17, 2023, 04:09 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Nov 15, 2023 | Sale | $30.00 | 2,915 | 87,450 | 1,764 | Nov 17, 2023, 04:09 PM | |
BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Dec 29, 2021 | Buy | $14.23 | 1,764 | 25,102 | 1,764 | Jan 03, 2022, 07:53 PM |